Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

Respirology - Tập 20 Số 7 - Trang 1010-1022 - 2015
Nathan Hambly1,2,3, Chiko Shimbori1,2,3, Martin Kolb1,2,3
1Department of Medicine, McMaster University Hamilton, Hamilton, ON, Canada
2Firestone Institute for Respiratory Health, Hamilton, ON, Canada
3St Joseph's Healthcare, Hamilton, ON, Canada

Tóm tắt

AbstractIdiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic lung disease associated with high morbidity and poor survival. Characterized by substantial disease heterogeneity, the diagnostic considerations, clinical course and treatment response in individual patients can be variable. In the past decade, with the advent of high‐throughput proteomic and genomic technologies, our understanding of the pathogenesis of IPF has greatly improved and has led to the recognition of novel treatment targets and numerous putative biomarkers. Molecular biomarkers with mechanistic plausibility are highly desired in IPF, where they have the potential to accelerate drug development, facilitate early detection in susceptible individuals, improve prognostic accuracy and inform treatment recommendations. Although the search for candidate biomarkers remains in its infancy, attractive targets such as MUC5B and MPP7 have already been validated in large cohorts and have demonstrated their potential to improve clinical predictors beyond that of routine clinical practices. The discovery and implementation of future biomarkers will face many challenges, but with strong collaborative efforts among scientists, clinicians and the industry the ultimate goal of personalized medicine may be realized.

Từ khóa


Tài liệu tham khảo

10.1164/rccm.2009-040GL

10.1378/chest.09-1002

10.1164/rccm.201006-0894CI

10.1378/chest.111.1.51

10.1164/rccm.200604-520OC

10.7326/0003-4819-156-10-201205150-00004

10.1164/rccm.201011-1790OC

10.1164/rccm.2111053

10.7326/0003-4819-134-2-200101160-00015

10.1164/rccm.200810-1615OC

Kasper M, 1996, Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis, Histol. Histopathol., 11, 463

10.1165/ajrcmb.24.1.4040

10.1016/j.biocel.2007.11.020

10.1016/S0140-6736(11)60052-4

10.7326/0003-4819-134-2-200101160-00015

10.1159/000357598

10.1056/NEJMoa1113354

10.1056/NEJMoa1402582

10.1016/S0140-6736(11)60405-4

10.1056/NEJMoa1402584

10.1038/nm.2807

10.1126/scitranslmed.3005964

10.1164/rccm.201001-0076OC

10.1164/rccm.201203-0506OC

10.4049/jimmunol.1203476

10.1155/2013/769214

10.1006/cimm.2000.1687

10.1172/JCI40053

10.1172/JCI117131

10.1183/09031936.00077309

10.1097/MCP.0b013e328363f4de

10.1164/rccm.201312-2221PP

10.1152/ajplung.00108.2012

10.1165/rcmb.2012-0335OC

Pardo A, 2012, Role of matrix metaloproteases in idiopathic pulmonary fibrosis, Fibrogenesis Tissue Repair, 5, S9, 10.1186/1755-1536-5-S1-S9

10.1056/NEJMoa1013660

10.1056/NEJMoa066157

10.1073/pnas.0701009104

10.1016/S2213-2600(14)70124-9

10.1164/rccm.201304-0760OC

10.1111/j.1365-2796.2006.01704.x

10.1164/rccm.200404-571OC

10.1007/s00408-009-9223-x

10.1186/1465-9921-13-105

10.1164/rccm.201101-0058OC

10.1073/pnas.1009426107

10.1016/j.rmed.2004.04.018

10.1164/rccm.200810-1534OC

10.1016/j.rmed.2010.09.012

10.1164/rccm.200808-1201OC

10.1164/rccm.201309-1592OC

10.1371/journal.pone.0008959

10.1097/MCP.0b013e328356d03c

10.1067/mcp.2001.113989

10.1164/rccm.200804-550OC

10.1016/j.resinv.2012.02.001

10.1136/ard.59.4.257

10.1165/ajrcmb.17.4.2253

10.1016/j.bbrc.2005.10.144

10.1136/thorax.58.1.52

10.1164/ajrccm.165.3.2107134

10.1164/ajrccm.161.2.9905028

10.1016/S0962-8479(05)80010-3

10.1164/ajrccm.158.5.9803115

10.1378/chest.11-2735

10.1183/09031936.00005209

10.1016/S0925-4439(98)00060-X

10.1152/ajplung.00410.2011

10.1074/jbc.M309599200

10.1038/modpathol.3800149

10.1073/pnas.1107559108

10.1007/s00439-003-1015-4

10.1056/NEJM200102223440805

10.1152/ajplung.00382.2007

10.1136/thx.2004.026336

10.1074/jbc.M110.121467

10.1183/09031936.00034406

10.1183/09031936.02.00081102

10.1152/ajplung.90637.2008

10.1136/thorax.58.1.52

10.1183/09031936.02.00081102

10.1378/chest.08-2209

10.1164/ajrccm.162.3.9910080

10.1073/pnas.0804280105

10.1136/thoraxjnl-2012-202544

10.1152/ajplung.00014.2014

10.1056/NEJMc1013504

10.1136/thoraxjnl-2012-201786

10.1371/journal.pone.0070621

10.1016/S2213-2600(13)70045-6

10.1038/ng.2609

10.1164/rccm.201312-2219PP

10.1016/j.rmed.2010.05.014

10.1183/09031936.00201809

10.1148/radiol.13120816

10.1056/NEJMoa1216076

10.1001/jama.2013.5827

10.1513/AnnalsATS.201308‐263MG

10.1164/rccm.201403-0541OC

10.1152/ajpcell.1993.264.4.C995

10.1378/chest.11-1962

10.1164/rccm.2103112

10.1067/mlc.2000.105618

10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J

10.1513/pats.200601-012TK

10.1164/rccm.200504-644OC

10.1371/journal.pmed.0050093

10.1073/pnas.092134099

10.1111/j.1600-0463.2007.apm_697.x

10.1378/chest.07-2116

10.1183/09031936.00059810

10.1152/ajplung.00139.2012

10.1172/JCI12980

10.1046/j.1365-2613.2000.00163.x

10.1165/ajrcmb.24.3.4293

10.1371/journal.pmed.0020251

10.1074/jbc.M103608200

10.1038/labinvest.3700654

10.1016/S0002-9440(10)62289-4

10.1016/j.biocel.2008.02.012

10.1164/rccm.201407-1287OC

10.1016/j.rmed.2006.12.006

10.4049/jimmunol.181.7.5167

10.1056/NEJMoa073600

10.1097/ACI.0b013e3283306533

10.1146/annurev-physiol-012110-142250

10.1016/j.rmed.2010.02.026

10.1002/art.21257

10.1164/rccm.200509-1518OC

10.1002/art.22559

10.1159/000097133

10.1186/1465-9921-6-81

10.1164/rccm.200810-1596OC

10.1371/journal.pone.0005134

10.1136/thoraxjnl-2013-204596